478sek
-16,1 %
Date:2025-05-14Time:17:14:08Latest report:Q1-2025List:First NorthTicker:SENZA
Market Cap:141 msekEnterprise Value:106 msekNet Sales:57,0 msekEarnings:-18,9 msekEmployees:0ISIN:SE0010219626

Ratios

10-year key figure history for SenzaGen turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SenzaGen with index and moving average MA50 and MA200.

Stockprice:4,78
MA50:5,13
MA200:6,63
Price/MA200:-27,9 %
RSI (14):43,3
Price/MA50:-6,9 %

Description

Senzagen is a medical technology company. The company develops and carries out genomic in vitro tests, which means that the toxicological ability of various chemicals is not tested on animals but instead in test tubes. The company has developed a technological platform that is used to study the impact of substances produced by actors in the pharmaceutical, cosmetics, and chemical industries. Research and development take place from the head office in Lund.

Biotechnology